Rankings
▼
Calendar
CLDX FY 2012 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
$2B
FY 2012 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
+20.9% YoY
Gross Profit
$427,000
3.8% margin
Operating Income
-$58M
-518.5% margin
Net Income
-$59M
-527.8% margin
EPS (Diluted)
$-15.37
Cash Flow
Operating Cash Flow
-$50M
Free Cash Flow
-$50M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$126M
Total Liabilities
$30M
Stockholders' Equity
$96M
Cash & Equivalents
$25M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$9M
+20.9%
Gross Profit
$427,000
$146,000
+192.5%
Operating Income
-$58M
-$43M
-33.8%
Net Income
-$59M
-$45M
-32.0%
← FY 2011
All Quarters
FY 2013 →